Q3 2016 13F Holders as of 30 Sep 2016
-
Type / Class
-
Equity / BIOTECH ETF
-
Total 13F shares
-
1,398,623
-
Share change
-
+581,200
-
Total reported value
-
$161,120,204
-
Put/Call ratio
-
19%
-
Price per share
-
$115.20
-
Number of holders
-
77
-
Value change
-
+$67,555,899
-
Number of buys
-
33
-
Number of sells
-
27
Institutional Holders of VANECK ETF TRUST - BIOTECH ETF (BBH) as of Q3 2016
As of 30 Sep 2016,
VANECK ETF TRUST - BIOTECH ETF (BBH) was held by
77 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,398,623 shares.
The largest 10 holders included
ALLIANCEBERNSTEIN L.P., GOLDMAN SACHS GROUP INC, UBS Group AG, MORGAN STANLEY, MURPHY CAPITAL MANAGEMENT INC, ROYAL BANK OF CANADA, BANQUE PICTET & CIE SA, Cambridge Investment Research Advisors, Inc., Timber Hill LLC, and Strategic Financial Services, Inc,.
This page lists
77
institutional shareholders reporting positions in this security
for the Q3 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.